A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

Bertrand Coiffier, Barbara Pro, H. Miles Prince et al. · Journal of Clinical Oncology · 2012 · 674 citations

Medicine, Pharmacology, Pharmacotherapy +13

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

Owen A. O’Connor, Barbara Pro, Lauren Pinter‐Brown et al. · Journal of Clinical Oncology · 2011 · 643 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

Laurence de Leval, David S. Rickman, Caroline Thielen et al. · Blood · 2007 · 621 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo

Lauri L. Laichalk, David A. Thorley‐Lawson · Journal of Virology · 2004 · 530 citations

Life Sciences, Cell Biology, Infectious Diseases +9

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials

Nathalie Mourad, Nicolas Mounier, Josette Brière et al. · Blood · 2008 · 341 citations · Full text

Medicine, Hematology, Oncology +12